A major part of this market will be based on iPS cell technology. iPS-based blood products alone might reach 60 billion Yen in the late 2020ies.
China Bio news release, October 13, 2014
METI expects global regenerative medicine markets to reach 17,2 trillion Yen (126 billion €) by 2030